Ilmarinen Mutual Pension Insurance Co trimmed its position in CME Group Inc. (NASDAQ:CME – Free Report) by 20.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,611 shares of the financial services provider’s stock after selling 18,500 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in CME Group were worth $19,829,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of CME. West Family Investments Inc. raised its stake in CME Group by 1.2% during the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after acquiring an additional 37 shares in the last quarter. Asset Dedication LLC raised its stake in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares in the last quarter. Northwestern Mutual Investment Management Company LLC raised its stake in CME Group by 0.3% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after acquiring an additional 37 shares in the last quarter. Rehmann Capital Advisory Group raised its stake in CME Group by 4.3% during the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after acquiring an additional 37 shares in the last quarter. Finally, Atlatl Advisers LLC raised its stake in CME Group by 1.8% during the third quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock worth $574,000 after acquiring an additional 38 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
CME Group Price Performance
Shares of CME stock opened at $277.42 on Friday. The stock has a 50-day moving average price of $293.99 and a 200 day moving average price of $289.62. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $100.53 billion, a price-to-earnings ratio of 23.67, a PEG ratio of 3.12 and a beta of 0.23. CME Group Inc. has a 12 month low of $257.17 and a 12 month high of $329.16.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is 44.37%.
Insiders Place Their Bets
In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 44,044 shares of company stock worth $13,297,507. Insiders own 0.30% of the company’s stock.
Analyst Ratings Changes
CME has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft dropped their price objective on CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Jefferies Financial Group dropped their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. JPMorgan Chase & Co. increased their price objective on CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. Erste Group Bank upgraded CME Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, March 5th. Finally, TD Cowen lowered their target price on CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $305.29.
Read Our Latest Research Report on CME Group
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Read More
- Five stocks we like better than CME Group
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
